Many studies investigating systemic inflammation in psoriasis revealed that markers of inflammation (especially C-reactive protein, tumor necrosis factor [TNF]-α, intracellular adhesion molecule [ICAM]-1, E-selectin, and interleukin [IL]-1β, IL-6, IL-10) are increased in psoriatic patients, creating a systemic inflammatory state that could lead to comorbidities like cardiovascular diseases.7 Here, TNF is linked to cardiovascular disorder.